A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Large Simple Trial Evaluating the Use of BE1116 (4-Factor Prothrombin Complex Concentrate [Kcentra / Beriplex]) to Improve Survival in Patients With Traumatic Injury and Acute Major Bleeding
ClinicalTrials.gov NCT05568888
Research payments
$46,197,688
Through program year 2025, $46,197,688 in research payments was reported against A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Large Simple Trial Evaluating the Use of BE1116 (4-Factor Prothrombin Complex Concentrate [Kcentra / Beriplex]) to Improve Survival in Patients With Traumatic Injury and Acute Major Bleeding, across 2,539 payments, paid by CSL Behring.
- Paid by
- CSL Behring
- ClinicalTrials.gov
- NCT05568888
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,494,775 | 601 |
| 2024 | Research | $30,071,525 | 1,405 |
| 2023 | Research | $13,551,912 | 532 |
| 2022 | Research | $79,476 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Saman Arbabi Seattle, WA Named on 135 payments
- Joseph Dubose Austin, TX Named on 83 payments
- Grant Bochicchio Saint Louis, MO Named on 72 payments
- Tanya Anand Bakersfield, CA Named on 59 payments
- Thomas Schroeppel Colorado Springs, CO Named on 57 payments
- Samuel Ross Charlotte, NC Named on 55 payments
- Christine Leeper Pittsburgh, PA Named on 52 payments
- Charles Hu Chandler, AZ Named on 48 payments
- Jonathan Meizoso Miami, FL Named on 46 payments
- Martin Schreiber Portland, OR Named on 44 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.